Breaking News Instant updates and real-time market news.

FCX

Freeport McMoRan

$16.21

1.09 (7.21%)

, T

AT&T

$38.73

0.18 (0.47%)

07:35
11/25/16
11/25
07:35
11/25/16
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Wednesday in Freeport McMoRan (FCX), AT&T (T), Starbucks (SBUX), Target (TGT), Ctrip.com (CTRP), Fifth Third (FITB), GrubHub (GRUB), Fortinet (FTNT), XPO Logistics (XPO), and Gold Fields (GFI).

FCX

Freeport McMoRan

$16.21

1.09 (7.21%)

T

AT&T

$38.73

0.18 (0.47%)

SBUX

Starbucks

$57.59

0.47 (0.82%)

TGT

Target

$78.48

0.61 (0.78%)

CTRP

Ctrip.com

$40.99

-0.88 (-2.10%)

FITB

Fifth Third

$26.29

0.15 (0.57%)

GRUB

GrubHub

$37.93

0.79 (2.13%)

FTNT

Fortinet

$30.84

-0.31 (-1.00%)

XPO

XPO Logistics

$45.55

2.99 (7.03%)

GFI

Gold Fields

$3.05

-0.08 (-2.56%)

  • 29

    Nov

  • 29

    Nov

  • 05

    Dec

  • 07

    Dec

  • 12

    Dec

FCX Freeport McMoRan
$16.21

1.09 (7.21%)

11/17/16
DBAB
11/17/16
DOWNGRADE
Target $12.5
DBAB
Hold
Freeport McMoRan downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Chris Terry downgraded Freeport McMoRan to Hold citing valuation following the recent rally in the shares. The analyst keeps a $12.50 price target for the stock.
11/14/16
MACQ
11/14/16
NO CHANGE
Target $13
MACQ
Outperform
Freeport McMoRan price target raised to $13 from $9 at Macquarie
Macquarie analyst Anthony Young raised Freeport's price target to $13 from $9 in conjunction with the Commodities' team increase in copper price forecast by 17% in 2017 to $2.43/lb and 16% in 2018 to $2.13/lb. The analyst likes Freeport's leverage to the price of copper and expects the company to ultimately reach an agreement with the Indonesia government on the company's permit to export. Young has an Outperform rating on Freeport shares.
11/21/16
COWN
11/21/16
NO CHANGE
Target $20
COWN
Outperform
Freeport McMoRan price target raised to $20 from $15 at Cowen
Cowen analyst Anthony Rizzuto raised his price target on Freeport McMoRan to $20 from $15 as the company has regained its status as the "go-to" coper investment vehicle after the impressive action taken by management to right-size the balance sheet. Rizzuto reiterated his Outperform rating on Freeport McMoRan shares.
10/17/16
10/17/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Freeport McMoRan (FCX) reinstated with an Underperform at BofA/Merrill. 2. Novan (NOV) initiated with an Overweight at Piper Jaffray, an Outperform at Wedbush, and an Outperform at JMP Securities. 3. CapStar Financial (CSTR) initiated with a Market Perform at Keefe Bruyette, a Hold at Sandler O'Neill, and an Outperform at Raymond James. 4. Trade Desk (TTD) initiated with a Buy at Jefferies, an Outperform at RBC Capital, a Buy at Citi, a Buy at Needham, and an Outperform at Raymond James. 5. e.l.f. Beauty (ELF) initiated with a Neutral at JPMorgan, an Overweight at Piper Jaffray, a Market Perform at Wells Fargo, an Outperform at William Blair, a Hold at Stifel, a Buy at SunTrust, an Outperform at Cowen, and an Equal Weight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
T AT&T
$38.73

0.18 (0.47%)

11/02/16
PIVT
11/02/16
UPGRADE
Target $106
PIVT
Buy
Time Warner upgraded to Buy from Hold at Pivotal Research
Pivotal Research analyst Brian Wieser upgraded Time Warner (TWX) to Buy with a $106 price target following the company's Q3 results. The analyst sees value in the stock due to the pending buyout by AT&T (T).
11/04/16
DBAB
11/04/16
NO CHANGE
Target $108
DBAB
Buy
Time Warner risk/reward remains attractive, says Deutsche Bank
Deutsche Bank analyst Bryan Kraft believes Time Warner's (TWX) attractive risk/reward "remains in place." The analyst continue to see limited downside if the takeover by AT&T (T) is not approved by regulators. Time Warner trades at only 9% above its pre-deal speculation stock price, Kraft tells investors in a research note, while pointing out that he has a $95 standalone 12-month valuation for the shares. The analyst keeps a Buy rating on the shares with a $108 price target.
11/08/16
11/08/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hertz (HTZ) downgraded to Hold from Buy at Deutsche Bank and to Neutral from Buy at Northcoast. 2. AT&T (T) downgraded to Perform from Outperform at Oppenheimer with analyst Timothy Horan saying CenturyLink's (CTL) dividend is "relatively more attractive." 3. Bank of America (BAC) and Citizens Financial (CFG) downgraded to Hold from Buy at Deutsche Bank. 4. OneMain (OMF) downgraded to Market Perform from Outperform at Keefe Bruyette, to Neutral from Buy at Guggenheim, to Underperform from Buy at BofA/Merrill, to Neutral from Buy at Janney Capital, to Market Perform from Outperform at FBR Capital, and to Neutral from Outperform at Wedbush. 5. KeyCorp (KEY) and Goldman Sachs (GS) downgraded to Neutral from Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/08/16
OPCO
11/08/16
DOWNGRADE
OPCO
Perform
AT&T downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Timothy Horan downgraded AT&T (T) to Perform saying CenturyLink's (CTL) dividend is "relatively more attractive." The analyst this morning upgraded CenturyLink to Outperform. Horan also believes AT&T's acquisition of Time Warner (TWX) will face higher regulatory hurtles than CenturyLink's deal for Level 3 (LVLT). He expects the Time Warner deal to take 15 months to complete versus nine months for the Level 3 acquisition.
SBUX Starbucks
$57.59

0.47 (0.82%)

11/01/16
DBAB
11/01/16
NO CHANGE
Target $59
DBAB
Hold
Starbucks price target lowered to $59 from $64 at Deutsche Bank
Deutsche Bank analyst Brett Levy lowered his price target for Starbucks to $59 and keeps a Hold rating on the shares ahead of the company's Q4 results. After six-plus years of 5% or greater quarterly same-store-sales growth, Starbucks' recent down-tick to 4% SSS creates uncertainty in the minds of some investors, Levy tells investors in a research note. He prefers a cautious approach given the "near-term challenges across the landscape."
11/04/16
JEFF
11/04/16
NO CHANGE
Target $65
JEFF
Buy
Starbucks shares likely to open lower today, says Jefferies
Jefferies analyst Andy Barish expects shares of Starbucks to react negatively to last night's Q4 results. Starbucks announced an increase in partner and digital investments of $250M in FY17 following an increase of $160M in FY16 and its same-store-sales are likely to be at the lower end of guidance in the first half of the fiscal year, Baris tells investors in a post-earnings research note. The analyst, however, keeps a Buy rating and $65 price target on Starbucks. He believes the company is taking the rights steps to "support long-term global growth and competitive positioning." Starbucks is up 53c to $52.30 in pre-market trading
11/04/16
JPMS
11/04/16
NO CHANGE
Target $59
JPMS
Overweight
Starbucks valuation doesn't need beats and raises, says JPMorgan
JPMorgan analyst John Ivankoe believes Starbucks' current valuation no longer requires the "beat and raise" estimates of old. He believes the company's "long-term algorithm" is intact at 15% following the company's Q4 results. The analyst dropped his price target for Starbucks to $59 from $61 and keeps an Overweight rating on the shares.
11/21/16
BUCK
11/21/16
INITIATION
Target $59
BUCK
Neutral
Starbucks initiated with a Neutral at Buckingham
Buckingham analyst John Zolidis initiated Starbucks with a Neutral and a $59 price target.
TGT Target
$78.48

0.61 (0.78%)

09/30/16
GUGG
09/30/16
INITIATION
GUGG
Neutral
Target initiated with a Neutral at Guggenheim
09/23/16
BOFA
09/23/16
NO CHANGE
Target $55
BOFA
Buy
BofA thinks Verizon deal stays on track despite Yahoo data breach
Bank of America Merrill Lynch analyst Justin Post said that Yahoo's (YHOO) disclosure of the massive data breach impacting over 500M of its users is clearly a negative for the company that could result in email account closures, but he does not anticipate a major impact on Yahoo's business related to this breach, citing as evidence the fact that he is not aware of any significant business impairment or financial liability related to security breaches at LinkedIn (LNKD) in 2012 and at eBay (EBAY) in 2014. Post adds that the Target (TGT) data breach, which did include credit card info, is not directly comparable to Yahoo's breach. For Verizon (VZ) to back out of its acquisition agreement, Post thinks the company would need to assume Yahoo acted in bad faith during negotiations and that the Yahoo asset is impaired or comes with significant liability, neither of which he sees as being the case. The analyst keeps a Buy rating on Yahoo and bumped his target on the shares to $55 from $53, citing an increased price target on Alibaba (BABA) that a peer at the firm recently set.
09/16/16
09/16/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. GoPro (GPRO) initiated with a Buy at BofA/Merrill. 2. JetBlue (JBLU) initiated with an Outperform at Imperial Capital. 3. PepsiCo (PEP), Dr Pepper Snapple (DPS), and Monster Beverage (MNST) were initiated with an Outperform at Credit Suisse, while the firm initiated Boston Beer (SAM) with an Underperform. Credit Suisse also initiated Coca-Cola (KO) and Constellation Brands (STZ) with a Neutral. 4. lululemon (LULU) initiated with a Positive at Susquehanna. 5. Target (TGT) coverage assumed with a Neutral at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/16/16
FBCO
09/16/16
INITIATION
Target $65
FBCO
Neutral
Target coverage assumed with a Neutral at Credit Suisse
Credit Suisse analyst Edward Kelly assumed coverage on Target with a $65 price target, down from $72, citing an uncertain outlook, structural headwinds, and under investment.
CTRP Ctrip.com
$40.99

-0.88 (-2.10%)

11/14/16
OPCO
11/14/16
NO CHANGE
Target $55
OPCO
Outperform
Ctrip.com pullback creates attractive buying opportunity, says Oppenheimer
Oppenheimer analyst Jed Kelly believes the recent pullback in Ctrip.com's shares creates an attractive buying opportunity. The analyst expects "solid" Q3 results, with Q4 guidance likely bracketing Street estimates. He reiterates an Outperform rating and $55 price target on the shares.
11/25/16
HSBC
11/25/16
UPGRADE
HSBC
Buy
Ctrip.com upgraded to Buy from Hold at HSBC (yesterday)
11/25/16
JPMS
11/25/16
NO CHANGE
Target $55
JPMS
Overweight
JPMorgan turning more positive on Ctrip.com outlook
JPMorgan analyst Alex Yao says he's turning more positive on Ctrip.com's profit outlook following the company's Q3 results. The company's operating efficiency is improving while Qunar is turning profitable, Yao tells investors in a research note. The analyst views the Skyscanner acquisition as "solid progress" toward expanding into the addressable market for the outbound travel business. He maintains an Overweight rating on Ctrip.com with a $55 price target. The Chinese travel service provider is up $3.51 to $44.50 in pre-market trading.
11/25/16
SBSH
11/25/16
NO CHANGE
Target $55
SBSH
Buy
Ctrip.com strengthening position in global travel market, says Citi
Citi analyst Alicia Yap views Ctrip.com's Q3 results as "solid" and keeps a Buy rating on the shares with a slightly reduced price target of $55. The company, after dominating the China online travel booking landscape, is "stepping up its positioning" in the global online travel market via recent acquisitions, Yap tells investors in a research note. Ctrip has enhanced its global product offerings for both air and hotels, the analyst contends.
FITB Fifth Third
$26.29

0.15 (0.57%)

11/18/16
COMP
11/18/16
DOWNGRADE
Target $25.5
COMP
Neutral
Fifth Third downgraded to Neutral from Buy at Compass Point
Compass Point analyst Scott Valentin downgraded Fifth Third to Hold and raised its price target to $25.50 from $23 on valuation and said Trumps victory has pushed bank stocks to new near-term highs.
11/16/16
11/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Sysco (SYY) downgraded to Neutral from Outperform at Credit Suisse with analyst Edward Kelly saying Sysco shares are up 50% over the last 18 months and now views risk/reward as balanced. 2. Teva (TEVA) downgraded to Hold from Buy at Jefferies, to Equal Weight from Overweight at Morgan Stanley, and to Neutral from Buy at BTIG. 3. Bank of America (BAC) Capital One (COF) downgraded to Neutral from Outperform at Baird while the firm downgraded Fifth Third (FITB) to Underperform from Neutral. 4. Zions Bancorp (ZION) downgraded to Equal Weight from Overweight at Morgan Stanley and to Market Perform from Outperform at Bernstein. 5. Yingli Green Energy (YGE) downgraded to Sell from Buy at Axiom while the firm downgraded SolarCity (SCTY) and JA Solar (JASO) to Sell from Hold. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/16/16
BARD
11/16/16
DOWNGRADE
Target $21
BARD
Underperform
Fifth Third downgraded to Underperform from Neutral at Baird
Baird analyst David George downgraded Fifth Third to Underperform from Neutral as he thinks shares now reflect most of the benefit from the company's Project North Star efficiency program and that, more broadly, the post-election rally has largely discounted the potential benefits of rising interest rates, lower taxes, and more aggressive capital return in the bank space. However, he raised his price target for Fifth Third shares to $21 from $19.
11/16/16
BERN
11/16/16
DOWNGRADE
BERN
Market Perform
Fifth Third downgraded based on valuation at Bernstein
As noted earlier, Bernstein downgraded Fifth Third to Market Perform from Outperform. Analyst Kevin St. Pierre downgraded the stock, along with several other mid-cap banks, based on valuation. He says that mid-cap bank stocks have risen 33% since their June trough, entirely based on multiple expansion ,and he "struggles to find compelling upside" in any of them at these historically high levels. Fifth Third price target to $26 from $23.
GRUB GrubHub
$37.93

0.79 (2.13%)

11/11/16
LOOP
11/11/16
NO CHANGE
LOOP
Loop Capital sees U.S.-centric internet names outperforming in near-term
Following the election of Donald Trump as President and the Republican sweep in D.C., large cap internet names, those with more international revenues, and China-based companies have been underperforming, noted Loop Capital analyst Blake Harper. Larger caps, such as Alphabet (GOOG), Amazon (AMZN) and Facebook (FB), could continue to see more pressure given the potential for more restrictive trade and antitrust policies, while internet companies the large majority of their revenues from the U.S. and a narrower market focus - such as Angie's List (ANGI), Care.com (CRCM), GrubHub (GRUB), Quotient (QUOT), Bankrate (RATE), LendingTree (TREE), TrueCar (TRUE) and Yelp (YELP) - should outperform in the near-term, contends Harper.
11/14/16
STFL
11/14/16
UPGRADE
STFL
Buy
GrubHub upgraded to Buy from Hold at Stifel
11/14/16
STFL
11/14/16
UPGRADE
STFL
Buy
GrubHub upgraded on fundamentals, risk/reward at Stifel
As noted earlier, Stifel upgraded GrubHub to Buy from Hold. Analyst John Egbert says that the company's fundamentals are "strong," while its Q3 results were "respectable." He believes that the recent decline in the stock has made the shares' risk/reward ratio "compelling," while the company's competitive positioning is "stable." Target $46.
10/27/16
10/27/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. GrubHub (GRUB) upgraded to Buy from Neutral at Roth Capital with analyst Darren Aftahi saying he believes delivery is the catalyst for stronger growth, platform stickiness, and growth in earnings before interest, tax, depreciation and amortization per order. 2. Hershey (HSY) upgraded to Buy from Neutral at Citi with analyst David Driscoll citing expectations the shares will rebound in 2017. 3. Owens Corning (OC) downgraded to Neutral from Buy at CL King. 4. Logitech (LOGI) upgraded to Neutral from Underweight at JPMorgan with analyst Paul Coster citing the company's second quarter results. 5. VMware (VMW) upgraded to Buy from Neutral at Citi with analyst Walter Pritchard saying the company's "strong" trends in the third quarter look sustainable. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
FTNT Fortinet
$30.84

-0.31 (-1.00%)

10/28/16
JMPS
10/28/16
NO CHANGE
JMPS
Fortinet shares still attractive despite guidance miss, says JMP Securities
After Fortinet provided lower than expected Q4 revenue and EPS guidance, JMP Securities analyst Erik Suppiger says checks indicate that the company's longer term opportunity is "still attractive." The analyst says that the company's guidance for 23% quarter-over-quarter billings growth indicates that its subscription pipeline is still healthy, while it has room to increase its sales force productivity. Additionally, Suppiger believes that the company is "a prime candidate for activist investors," given its "lagging growth "and "low operating margins." He keeps a $34 price target and Outperform rating on the shares.
11/15/16
MSCO
11/15/16
UPGRADE
MSCO
Overweight
Fortinet upgraded to Overweight from Equal Weight at Morgan Stanley
11/15/16
11/15/16
UPGRADE
Target $39

Overweight
Fortinet upgraded to Overweight at Morgan Stanley
As previously reported, Morgan Stanley upgraded Fortinet to Overweight from Equal Weight and a $39 price target. Analyst Melissa Gorham is mover constructive on Fortinet heading into FY17 given the stable demand environment, free cash flow generation, easier comps, and more durable renewals.
11/15/16
11/15/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Fortinet (FTNT) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Melissa Gorham saying she is more constructive on Fortinet heading into fiscal 2017 given the stable demand environment, free cash flow generation, easier comps, and more durable renewals. 2. Advance Auto Parts (AAP) upgraded to Strong Buy from Outperform at Raymond James and to Positive from Neutral at Susquehanna following the company's quarterly report. 3. Chevron (CVX) upgraded to Buy from Outperform at CLSA while the firm also upgraded EOG Resources (EOG) to Outperform from Underperform. 4. Harley-Davidson (HOG) upgraded to Sector Perform from Underperform at RBC Capital with analyst Joseph Spak saying that risks to the company's growth have dissipated, partly due to the potential of President-elect Trump's policies to spark increased consumer spending. 5. Cheesecake Factory (CAKE) upgraded to Buy from Hold at Argus with analyst John Staszak saying investors should be attracted to Cheesecake by its dividend hikes, share repurchases, and ability to open new stores while generating consistent comparable sales growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
XPO XPO Logistics
$45.55

2.99 (7.03%)

10/28/16
SBSH
10/28/16
NO CHANGE
Target $38
SBSH
Buy
XPO Logistics TL sale a 'solid positive,' says Citi
Citi analyst Christian Wetherbee views XPO Logistics' sale of its TL business as a "solid positive" for its leverage, free cash flow and valuation. XPO will use the proceeds to delever and the asset intensity of the TL business took away from the free cash flow story and likely valuation, Wetherbee tells investors in a research note. He expects a positive share price reaction today and reiterates a Buy rating on XPO with a $38 price target.
11/23/16
SBSH
11/23/16
NO CHANGE
Target $54
SBSH
Buy
XPO Logistics price target raised to $54 from $38 at Citi
Citi analyst Christian Wetherbee raised his price target for XPO Logistics to $54 after hosting meeting with the company's management. The investment case is as strong as it's been, Wetherbee tells investors in a research note. The analyst sees potential for multiple expansion now that XPO "has pivoted into the execution phase of its life cycle." He reiterates a Buy rating on the shares.
11/02/16
DBAB
11/02/16
INITIATION
Target $60
DBAB
Buy
XPO Logistics initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Amit Mehrotra started XPO Logistics with a Buy rating and $60 price target. The analyst calls XPO his top Transportation pick. He sees 80% upside as management's "massive transformation enters harvesting stage."
08/09/16
OPCO
08/09/16
NO CHANGE
Target $42
OPCO
Outperform
XPO Logistics price target raised to $42 from $33 at Oppenheimer
Oppenheimer analyst Scott Schneeberger raised his price target for XPO Logistics to $42 from $33 following a "strong" Q2. The analyst envisions potential multiple enhancement over coming years as Con-way synergies/operational efficiencies are achieved, margin expands/free cash flow builds and financial leverage declines. Schneeberger reiterates an Outperform rating on the shares.
GFI Gold Fields
$3.05

-0.08 (-2.56%)

06/27/16
GSCO
06/27/16
UPGRADE
GSCO
Neutral
Gold Fields upgraded to Neutral from Sell at Goldman
07/08/16
GSCO
07/08/16
UPGRADE
GSCO
Buy
Gold Fields upgraded to Buy from Neutral at Goldman
07/12/16
JPMS
07/12/16
UPGRADE
Target $5.61
JPMS
Neutral
Gold Fields upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Allan Cooke upgraded Gold Fields to Neutral citing the stock's underperformance this year. The analyst raised his price target for the shares to $5.61 from $4.
09/02/16
MACQ
09/02/16
UPGRADE
MACQ
Outperform
Gold Fields upgraded to Outperform from Neutral at Macquarie (earlier)
Macquarie analyst Yatish Chowthee upgraded earlier today Gold Fields to Outperform following meetings with management and the company's first half of 2016 results. The analyst believes Gold Fields' turnaround at South Deep is gaining momentum. Chowthee has a R90 price target, which represents around 23% upside.

TODAY'S FREE FLY STORIES

NOV

National Oilwell

$35.37

0.19 (0.54%)

10:52
09/20/17
09/20
10:52
09/20/17
10:52
Options
National Oilwell calls outpace puts 18:1 as shares jump »

National Oilwell calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Oct

ZLAB

Zai Lab

10:51
09/20/17
09/20
10:51
09/20/17
10:51
Syndicate
Breaking Syndicate news story on Zai Lab »

Zai Lab indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

STX

Seagate

$32.18

-1.34 (-4.00%)

10:50
09/20/17
09/20
10:50
09/20/17
10:50
Options
Short-term calls on Seagate see interest for a second time this week »

Short-term calls on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TFX

Teleflex

$237.42

-2.3252 (-0.97%)

10:47
09/20/17
09/20
10:47
09/20/17
10:47
Conference/Events
Teleflex management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 01

    Dec

OFIX

Orthofix

$48.51

-0.49 (-1.00%)

10:45
09/20/17
09/20
10:45
09/20/17
10:45
Conference/Events
Orthofix management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

PFE

Pfizer

$35.93

0.475 (1.34%)

10:45
09/20/17
09/20
10:45
09/20/17
10:45
Options
Pfizer call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 18

    Oct

  • 31

    Oct

10:45
09/20/17
09/20
10:45
09/20/17
10:45
General news
Euro$ interest rate futures are relatively buoyant »

Euro$ interest rate…

ZLAB

Zai Lab

10:44
09/20/17
09/20
10:44
09/20/17
10:44
Syndicate
Breaking Syndicate news story on Zai Lab »

Zai Lab indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

NKTR

Nektar

$21.75

-0.85 (-3.76%)

10:44
09/20/17
09/20
10:44
09/20/17
10:44
Conference/Events
Nektar management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 25

    Sep

MAT

Mattel

$15.05

0.18 (1.21%)

, HAS

Hasbro

$94.99

1.75 (1.88%)

10:44
09/20/17
09/20
10:44
09/20/17
10:44
Hot Stocks
Toymakers in focus after Toys"R"Us files for bankruptcy, Amazon could benefit »

Shares of toymakers,…

MAT

Mattel

$15.05

0.18 (1.21%)

HAS

Hasbro

$94.99

1.75 (1.88%)

JAKK

JAKKS Pacific

$2.83

-0.025 (-0.88%)

KKR

KKR

$19.24

0.15 (0.79%)

VNO

Vornado

$73.34

-0.03 (-0.04%)

AMZN

Amazon.com

$969.86

-4.33 (-0.44%)

WMT

Wal-Mart

$80.29

0.24 (0.30%)

JPM

JPMorgan

$94.12

0.18 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 02

    Oct

  • 10

    Oct

  • 12

    Oct

  • 22

    Oct

  • 23

    Oct

  • 16

    Nov

  • 21

    Nov

  • 20

    Feb

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

MODN

Model N

$13.35

-0.15 (-1.11%)

10:43
09/20/17
09/20
10:43
09/20/17
10:43
Conference/Events
Model N management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 16

    Nov

MMM

3M

$210.50

-3.06 (-1.43%)

10:43
09/20/17
09/20
10:43
09/20/17
10:43
Hot Stocks
Analyst says sell 3M amid slowdown in autos, electronics »

JPMorgan downgraded 3M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

ODP

Office Depot

$4.35

-0.07 (-1.58%)

, ADP

ADP

$107.48

0.93 (0.87%)

10:42
09/20/17
09/20
10:42
09/20/17
10:42
Hot Stocks
Office Depot says David Bleisch joins as Chief Legal Officer »

Office Depot (ODP)…

ODP

Office Depot

$4.35

-0.07 (-1.58%)

ADP

ADP

$107.48

0.93 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZLAB

Zai Lab

10:40
09/20/17
09/20
10:40
09/20/17
10:40
Syndicate
Zai Lab indicated to open at $23, IPO priced at $18 »

Zai Lab (ZLAB) priced 8M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

10:40
09/20/17
09/20
10:40
09/20/17
10:40
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

APC

Anadarko

$44.64

0.88 (2.01%)

10:35
09/20/17
09/20
10:35
09/20/17
10:35
Options
Anadarko put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

JCOM

j2 Global

$73.37

-1.52 (-2.03%)

10:35
09/20/17
09/20
10:35
09/20/17
10:35
Conference/Events
j2 Global management to meet with JMP Securities »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 28

    Sep

PFE

Pfizer

$35.85

0.4 (1.13%)

, JNJ

Johnson & Johnson

$133.60

-1.62 (-1.20%)

10:34
09/20/17
09/20
10:34
09/20/17
10:34
Hot Stocks
Pfizer takes J&J to court as analysts shake up pharma ratings »

Morgan Stanley analyst…

PFE

Pfizer

$35.85

0.4 (1.13%)

JNJ

Johnson & Johnson

$133.60

-1.62 (-1.20%)

LLY

Eli Lilly

$82.24

0.505 (0.62%)

NVS

Novartis

$86.11

0.26 (0.30%)

ABBV

AbbVie

$86.90

0.53 (0.61%)

BMY

Bristol-Myers

$63.08

0.1532 (0.24%)

AGN

Allergan

$211.28

-3.725 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 22

    Sep

  • 22

    Sep

  • 24

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 17

    Oct

  • 18

    Oct

  • 26

    Oct

  • 31

    Oct

  • 09

    Nov

  • 05

    Mar

  • 17

    May

10:31
09/20/17
09/20
10:31
09/20/17
10:31
General news
Crude inventories for week of September 15 »

Crude oil inventories…

PYPL

PayPal

$63.83

0.91 (1.45%)

10:30
09/20/17
09/20
10:30
09/20/17
10:30
Recommendations
PayPal analyst commentary  »

PayPal price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 22

    Oct

  • 29

    Nov

10:30
09/20/17
09/20
10:30
09/20/17
10:30
General news
The 1.7% U.S. August existing home sales drop »

The 1.7% U.S. August…

AAXN

Axon

$22.07

-0.33 (-1.47%)

10:29
09/20/17
09/20
10:29
09/20/17
10:29
Periodicals
Studies about Taser's safety were overstated, Reuters reports »

Claims about early…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$317.93

-0.25 (-0.08%)

, CBAY

CymaBay

10:29
09/20/17
09/20
10:29
09/20/17
10:29
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

BIIB

Biogen

$317.93

-0.25 (-0.08%)

CBAY

CymaBay

EVH

Evolent Health

$16.18

0.5299 (3.39%)

EPZM

Epizyme

$19.25

1.4 (7.84%)

INTU

Intuit

$145.34

1.54 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 03

    Oct

  • 22

    Oct

  • 25

    Oct

JNJ

Johnson & Johnson

$133.80

-1.42 (-1.05%)

, UAL

United Continental

$58.01

0.47 (0.82%)

10:29
09/20/17
09/20
10:29
09/20/17
10:29
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

JNJ

Johnson & Johnson

$133.80

-1.42 (-1.05%)

UAL

United Continental

$58.01

0.47 (0.82%)

IR

Ingersoll-Rand

$88.85

-1.61 (-1.78%)

LB

L Brands

$37.40

-1.83 (-4.66%)

YAHOY

Yahoo Japan

$9.02

-0.03 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 27

    Sep

  • 02

    Oct

  • 17

    Oct

PFE

Pfizer

$35.91

0.455 (1.28%)

, PGR

Progressive

$47.57

-0.065 (-0.14%)

10:29
09/20/17
09/20
10:29
09/20/17
10:29
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

PFE

Pfizer

$35.91

0.455 (1.28%)

PGR

Progressive

$47.57

-0.065 (-0.14%)

AAL

American Airlines

$44.38

-0.93 (-2.05%)

LUV

Southwest

$53.77

0.23 (0.43%)

POST

Post Holdings

$86.68

0.32 (0.37%)

NDSN

Nordson

$114.62

0.12 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 02

    Oct

  • 18

    Oct

  • 31

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.